Merck snags Chinese obesity drug in nearly $2 billion deal ...Middle East

Merck will gain the exclusive global license for Chinese drugmaker Hansoh’s HS-10535, an experimental oral drug that targets GLP-1 receptors. Read More

Read More Details
Finally We wish PressBee provided you with enough information of ( Merck snags Chinese obesity drug in nearly $2 billion deal )

Also on site :

• Braves Expected To Activate Spencer Strider On Tuesday
• SNL season finale cold open ridicules Trump boasting about ‘pre-bribe’ of $400m Qatar jet
• VUZ gets $12M for its immersive video experiences across emerging markets and the U.S.